This product will give you access to the webinar only. If you would like continuing education credit for the webinar, see the table below to purchase the webinar + CME/CMLE or webinar + SAM.


In this webinar, Antonia Sepulveda provides an overview of the American Society of Clinical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and American Society of Clinical Oncology (ASCO)'s evidence-based practice guideline on molecular marker testing for patients with colorectal carcinoma that identifies opportunities for improving patient outcomes.

The guideline addresses a wide range of molecular markers appropriate for testing in patients with early and advanced colorectal cancer which aids in establishing standard molecular marker testing to help guide targeted therapy decisions and advance personalized care for colorectal cancer patients.

Practice Guideline Available Here

Speaker: Antonia R. Sepulveda MD, PhD

Duration: 1.0 hr

Level of Instruction: Basic

If you would like continuing education credit, click on the links below.

Credit Type

Number of Credit Hours

Click on link to purchase:



Purchase webinar + CME/CMLE

(Free for AMP members)



Purchase webinar + SAM

(Free for AMP members)

Continuing Education Credit must be purchased and claimed by March 31, 2020

* You may not submit SAMs and CME/CMLE credit for the same content.

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.


Course Information
Course Date:
March 31, 2017
Course Objectives
  • Discuss the recently published molecular testing guidelines for colorectal cancer.
  • Describe current laboratory practice guidelines for the use and performance of molecular testing in the evaluation of colorectal cancer.
  • Evaluate prognosis and prediction of response to therapies for the following markers: KRAS, NRAS, BRAF, PIK3CA, PTEN, DNA mismatch repair/microsatellite instability.
Molecular Biomarkers for the Evaluation of Colorectal Cancer
Speaker Information
Antonia R. Sepulveda MD, PhD  [ view bio ]
Individual topic purchase: Selected
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $195.00